Identification and Evaluation of Controlled Trials in Pediatric Cardiology: Crowdsourced Scoping Review and Creation

Jenna Ashkanase1, Nassr Nama2, Ryan Vimukthie Sandarage3

  • 1Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada; Department of Cardiology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.

Insights

Contrary to perception, nearly 1,000 randomized controlled trials (RCTs) exist in pediatric cardiology. An open-access database now catalogs these studies, aiding clinicians and researchers in pediatric cardiac care.

Area of Science:

  • Pediatric Cardiology
  • Clinical Trials
  • Evidence-Based Medicine

Background:

  • Pediatric cardiac disease causes significant morbidity, mortality, and healthcare utilization.
  • A perception exists of limited high-quality studies, especially randomized controlled trials (RCTs), in pediatric cardiology.
  • The need for a comprehensive overview of existing RCTs in this field is apparent.

Purpose of the Study:

  • To identify, examine, and map the range of RCTs conducted in children with cardiac conditions.
  • To develop a searchable, open-access database of these RCTs.
  • To address the perceived paucity of high-quality research in pediatric cardiology.

Main Methods:

  • A comprehensive literature search of MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials was performed.
  • Included were all English-language RCTs enrolling children (0-21 years) with cardiac conditions up to 2018.
  • Data extraction and risk of bias assessments were conducted in duplicate via crowdsourcing and entered into an online database.

Main Results:

  • A total of 933 RCTs met the eligibility criteria.
  • Congenital heart disease (79.8%) and medications (63.3%) were frequently studied populations and interventions.
  • Just over half of trials (53.4%) clearly identified a primary outcome, and less than half (46.6%) fully documented randomization.

Conclusions:

  • There are nearly 1,000 published RCTs in pediatric cardiology, challenging the perception of limited research.
  • The created open-access database serves as a valuable resource for clinicians and researchers.
  • This database facilitates efficient and comprehensive literature reviews for pediatric cardiac care.

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
334
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.1K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
480
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
174